Cargando…
Intraoral and maxillofacial abnormalities in patients with autosomal dominant hyper-IgE syndrome
Autosomal dominant hyper-IgE syndrome (AD-HIES) is an inborn error of immunity (IEI) caused by a dominant-negative mutation in the signal transducer and activator of transcription 3 (STAT 3). This disease is characterized by chronic eczematoid dermatitis, recurrent staphylococcal skin abscesses, pne...
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Termedia Publishing House
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10604639/ https://www.ncbi.nlm.nih.gov/pubmed/37901871 http://dx.doi.org/10.5114/ceji.2023.130874 |
_version_ | 1785126882724806656 |
---|---|
author | Tar, Ildikó Szegedi, Márta Krasuska-Sławińska, Ewa Heropolitańska-Pliszka, Edyta Bernatowska, Ewa A. Öncü, Elif Keles, Sevgi Guner, Sukru N. Reisli, Ismail Gesheva, Nevena Naumova, Elissaveta Izakovicova-Holla, Lydie Litzman, Jiri Savchak, Igor Kostyuchenko, Larysa Erdõs, Melinda |
author_facet | Tar, Ildikó Szegedi, Márta Krasuska-Sławińska, Ewa Heropolitańska-Pliszka, Edyta Bernatowska, Ewa A. Öncü, Elif Keles, Sevgi Guner, Sukru N. Reisli, Ismail Gesheva, Nevena Naumova, Elissaveta Izakovicova-Holla, Lydie Litzman, Jiri Savchak, Igor Kostyuchenko, Larysa Erdõs, Melinda |
author_sort | Tar, Ildikó |
collection | PubMed |
description | Autosomal dominant hyper-IgE syndrome (AD-HIES) is an inborn error of immunity (IEI) caused by a dominant-negative mutation in the signal transducer and activator of transcription 3 (STAT 3). This disease is characterized by chronic eczematoid dermatitis, recurrent staphylococcal skin abscesses, pneumonia, pneumatoceles, and extremely high serum IgE levels. Loss-of-function STAT3 mutations may also result in distinct non-immunologic features such as dental, facial, skeletal, and vascular abnormalities, central nervous system malformations and an increased risk for bone fractures. Prophylactic treatment of Candida infections and prophylactic antimicrobial therapy for staphylococcal skin infections and sinopulmonary infections are essential. An awareness of the oral and maxillofacial features of HIES may facilitate early diagnosis with genetic counselling and may improve future patient care. This study describes oral, dental, and maxillofacial manifestations in 14 patients with genetically defined AD-HIES. We also review the literature and propose recommendations for the complex care of patients with this rare primary immunodeficiency. |
format | Online Article Text |
id | pubmed-10604639 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Termedia Publishing House |
record_format | MEDLINE/PubMed |
spelling | pubmed-106046392023-10-28 Intraoral and maxillofacial abnormalities in patients with autosomal dominant hyper-IgE syndrome Tar, Ildikó Szegedi, Márta Krasuska-Sławińska, Ewa Heropolitańska-Pliszka, Edyta Bernatowska, Ewa A. Öncü, Elif Keles, Sevgi Guner, Sukru N. Reisli, Ismail Gesheva, Nevena Naumova, Elissaveta Izakovicova-Holla, Lydie Litzman, Jiri Savchak, Igor Kostyuchenko, Larysa Erdõs, Melinda Cent Eur J Immunol Clinical Immunology Autosomal dominant hyper-IgE syndrome (AD-HIES) is an inborn error of immunity (IEI) caused by a dominant-negative mutation in the signal transducer and activator of transcription 3 (STAT 3). This disease is characterized by chronic eczematoid dermatitis, recurrent staphylococcal skin abscesses, pneumonia, pneumatoceles, and extremely high serum IgE levels. Loss-of-function STAT3 mutations may also result in distinct non-immunologic features such as dental, facial, skeletal, and vascular abnormalities, central nervous system malformations and an increased risk for bone fractures. Prophylactic treatment of Candida infections and prophylactic antimicrobial therapy for staphylococcal skin infections and sinopulmonary infections are essential. An awareness of the oral and maxillofacial features of HIES may facilitate early diagnosis with genetic counselling and may improve future patient care. This study describes oral, dental, and maxillofacial manifestations in 14 patients with genetically defined AD-HIES. We also review the literature and propose recommendations for the complex care of patients with this rare primary immunodeficiency. Termedia Publishing House 2023-09-05 2023 /pmc/articles/PMC10604639/ /pubmed/37901871 http://dx.doi.org/10.5114/ceji.2023.130874 Text en Copyright © 2023 Termedia https://creativecommons.org/licenses/by-nc-sa/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0). License (http://creativecommons.org/licenses/by-nc-sa/4.0/ (https://creativecommons.org/licenses/by-nc-sa/4.0/) ) |
spellingShingle | Clinical Immunology Tar, Ildikó Szegedi, Márta Krasuska-Sławińska, Ewa Heropolitańska-Pliszka, Edyta Bernatowska, Ewa A. Öncü, Elif Keles, Sevgi Guner, Sukru N. Reisli, Ismail Gesheva, Nevena Naumova, Elissaveta Izakovicova-Holla, Lydie Litzman, Jiri Savchak, Igor Kostyuchenko, Larysa Erdõs, Melinda Intraoral and maxillofacial abnormalities in patients with autosomal dominant hyper-IgE syndrome |
title | Intraoral and maxillofacial abnormalities in patients with autosomal dominant hyper-IgE syndrome |
title_full | Intraoral and maxillofacial abnormalities in patients with autosomal dominant hyper-IgE syndrome |
title_fullStr | Intraoral and maxillofacial abnormalities in patients with autosomal dominant hyper-IgE syndrome |
title_full_unstemmed | Intraoral and maxillofacial abnormalities in patients with autosomal dominant hyper-IgE syndrome |
title_short | Intraoral and maxillofacial abnormalities in patients with autosomal dominant hyper-IgE syndrome |
title_sort | intraoral and maxillofacial abnormalities in patients with autosomal dominant hyper-ige syndrome |
topic | Clinical Immunology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10604639/ https://www.ncbi.nlm.nih.gov/pubmed/37901871 http://dx.doi.org/10.5114/ceji.2023.130874 |
work_keys_str_mv | AT tarildiko intraoralandmaxillofacialabnormalitiesinpatientswithautosomaldominanthyperigesyndrome AT szegedimarta intraoralandmaxillofacialabnormalitiesinpatientswithautosomaldominanthyperigesyndrome AT krasuskasławinskaewa intraoralandmaxillofacialabnormalitiesinpatientswithautosomaldominanthyperigesyndrome AT heropolitanskapliszkaedyta intraoralandmaxillofacialabnormalitiesinpatientswithautosomaldominanthyperigesyndrome AT bernatowskaewaa intraoralandmaxillofacialabnormalitiesinpatientswithautosomaldominanthyperigesyndrome AT oncuelif intraoralandmaxillofacialabnormalitiesinpatientswithautosomaldominanthyperigesyndrome AT kelessevgi intraoralandmaxillofacialabnormalitiesinpatientswithautosomaldominanthyperigesyndrome AT gunersukrun intraoralandmaxillofacialabnormalitiesinpatientswithautosomaldominanthyperigesyndrome AT reisliismail intraoralandmaxillofacialabnormalitiesinpatientswithautosomaldominanthyperigesyndrome AT geshevanevena intraoralandmaxillofacialabnormalitiesinpatientswithautosomaldominanthyperigesyndrome AT naumovaelissaveta intraoralandmaxillofacialabnormalitiesinpatientswithautosomaldominanthyperigesyndrome AT izakovicovahollalydie intraoralandmaxillofacialabnormalitiesinpatientswithautosomaldominanthyperigesyndrome AT litzmanjiri intraoralandmaxillofacialabnormalitiesinpatientswithautosomaldominanthyperigesyndrome AT savchakigor intraoralandmaxillofacialabnormalitiesinpatientswithautosomaldominanthyperigesyndrome AT kostyuchenkolarysa intraoralandmaxillofacialabnormalitiesinpatientswithautosomaldominanthyperigesyndrome AT erdosmelinda intraoralandmaxillofacialabnormalitiesinpatientswithautosomaldominanthyperigesyndrome |